Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biopol ChemicalsNSE:BIOPOL -2.82%21 EPS without NRI is ₹ as of Mar. 2026. GuruFocus rates NSE:BIOPOL with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 1,256 Chemicals companies, Biopol Chemicals ranks worse than 79617.75% on this metric.
Biopol Chemicals's earnings per share without non-recurring items for the
six
months ended in Mar. 2026 was ₹6.18.
During the past 12 months, Biopol Chemicals's average earnings per share (NRI) Growth Rate was 171.40% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Biopol Chemicals's EPS without NRI or its related term are showing as below:
NSE:BIOPOL's 3-Year EPS without NRI Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: -1.45 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
Biopol Chemicals (NSE:BIOPOL) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Biopol Chemicals EPS without NRI Related Terms
Biopol Chemicals EPS without NRI Historical Data
* Premium members only.
The historical data trend for Biopol Chemicals's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biopol Chemicals EPS without NRI Chart
Biopol Chemicals Annual Data
Trend
Mar24
Mar25
Mar26
EPS without NRI
2.74
3.99
10.83
Biopol Chemicals Semi-Annual Data
Mar24
Mar25
Mar26
EPS without NRI
0.00
2.78
6.18
NSE:BIOPOL vs LIN, SHW, ECL: EPS without NRI Comparison
For the Specialty Chemicals subindustry, Biopol Chemicals's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biopol Chemicals PE Ratio without NRI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Biopol Chemicals's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Biopol Chemicals's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biopol Chemicals (NSE:BIOPOL) has a EPS without NRI of ₹ as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Biopol Chemicals and its competitors. According to the industry distribution chart, Biopol Chemicals ranks #999999 out of 1256 companies in the Chemicals industry.
Is Biopol Chemicals' EPS without NRI too high?
Biopol Chemicals' current EPS without NRI is ₹. Based on the distribution chart, Biopol Chemicals ranks #999999 out of 1256 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Biopol Chemicals has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' EPS without NRI compare to LIN and SHW?
According to the Chemicals industry distribution chart, Biopol Chemicals ranks #999999 out of 1256 companies for EPS without NRI. This places Biopol Chemicals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Chemicals company?
A good EPS without NRI depends on the Chemicals industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Biopol Chemicals and its competitors. Biopol Chemicals's current EPS without NRI is ₹. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current EPS without NRI of ₹. The current EPS without NRI is ₹. Biopol Chemicals' overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current EPS without NRI is ₹ as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressStreet No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
21GF Score
Get the complete analysis for NSE:BIOPOL
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BIOPOL has been successfully added to your 
